That projection starts with first half 2025 semaglutide sales of about $16.4 billion (Ozempic about $9.4 billion, Wegovy roughly $5.4 billion, Rybelsus about $1.7 billion), annualizes that run rate to approximately $33 billion for full-year 2025, and incorporates Novos statement that recent U.S
A GP can assess whether hormonal investigations are warranted for example, checking testosterone, oestrogen, thyroid function, or prolactin levels and can refer to an endocrinologist or sexual health specialist if appropriate
doi: 10.1126/scitranslmed.aar7047 101 FDA U
All 3 are designed to be self injected see below for more details on how these medicines work
For example, if you go through a service like Ro for GLP-1s or other drugs, those companies are sourcing from a smaller compounding pharmacy they dont manufacture it themselves
CtMCarrireKAlbergaAS